Download Fråga-svar Bosnien-Hercegovina. Behandling för cystisk fibros

2012-02-281
Fråga-svar
Bosnien-Hercegovina. Behandling för cystisk
fibros
Fråga
Vad finns det för behandling i Bosnien-Hercegovina för en person med
cystisk fibros?
Svar
International Organization for Migration (IOM), Country Fact Sheet 2011.
Bosnia and Herzegovina:
”The additional cost of health insurance for each family member is 5
USD per month.
Private health institutions and clinics in Bosnia and Herzegovina do
not have cooperative agreements with public health institutions.
Therefore, the cost of medical treatment in private clinics must be
covered fully by the patient.
Pensioners from the Federation of Bosnia and Herzegovina can
obtain health insurance in the Republic of Srpska. Similarly,
pensioners from the Republic of Srpska are covered by health
insurance in the Federation of Bosnia and Herzegovina.
More than 100 medicaments are fully covered by the Funds for
Health Insurance in Bosnia and Herzegovina. Medicaments not
included in the list must be paid by the patient. Specific medications
not available locally may be provided from abroad through an
agreement with local pharmacies.
Costs of medications obtained from abroad also must be paid by the
patient.”
1
Uppdaterad 2013-10-18
European Commission, CORDIS News, Why cystic fibrosis patients
live longer in some countries, 2010-03-19:
“The study showed that the average age of CF sufferers throughout
Europe is 16.3 years with a difference of 4.9 years between EU (17
years) and non-EU countries (12.1 years). The proportion of patients
over the age of 40 was also higher in the EU countries (5%) than in
non-EU countries (2%). In addition, the diagnosis of CF in children
under one year of age is rare in non-EU countries, something that
could be due to a lack of data or to unrecognised deaths of babies
with CF.
The authors say: "We have shown that far fewer children and
young adults have cystic fibrosis in non-EU countries than we
expected. This finding is reinforced by the increased chance of
patients surviving to 40 years in EU countries, even if they
have the [most common and severe form of CF] mutation."
Denna sammanställning av information/länkar är baserad på informationssökningar gjorda
under en begränsad tid. Den är sammanställd utifrån noggrant utvalda och allmänt tillgängliga
informationskällor. Alla använda källor refereras. All information som presenteras, med
undantag av obestridda/uppenbara fakta, har dubbelkontrollerats om inget annat anges.
Sammanställningen gör inte anspråk på att vara uttömmande och bör inte tillmätas exklusivt
bevisvärde i samband med avgörandet av ett enskilt ärende.
Informationen i sammanställningen återspeglar inte nödvändigtvis Migrationsverkets
officiella ståndpunkt i en viss fråga och det finns ingen avsikt att genom sammanställningen
göra politiska ställningstaganden.
Refererade dokument bör läsas i sitt sammanhang.
Källförteckning
European Commission, CORDIS News, Why cystic fibrosis patients live
longer in some countries, 2010-03-19
http://cordis.europa.eu/fetch?CALLER=FP6_NEWS&ACTION=D&DOC=
1&CAT=NEWS&QUERY=01278528de19:1d11:27f6cdb3&RCN=31899
International Organization for Migration (IOM), Country Fact Sheet 2011.
Bosnia and Herzegovina, 2011-10-31 (Lifos 26721)
http://www.bamf.de/SharedDocs/MILoDB/DE/Rueckkehrfoerderung/Laenderinformationen/Informationsblaetter/c
fs-bosnien-herzegowina-download-englisch.pdf?__blob=publicationFile